Adding carboplatin to presurgery chemo improved disease-free survival for patients with TNBC
12/10/2015

Previous results from GeparSixto showed carboplatin also increased pathologic complete responses.

New data for Gazyvaro demonstrate leukaemia patients can live 3 years longer without treatment vs. standard of care
12/09/2015

New data from two different studies unveiled during the 57th ASH annual meeting highlight the efficacy and safety of Gazyvaro for the treatment of patients with previously untreated chronic...

Blincyto (blinatumomab) data shows benefit in Phase 2 trial in all patients with persistent or recurrent minimal residual disease
12/09/2015

Amgen has announced that new data from three Phase 2 trials support the efficacy and safety of BLINCYTO® (blinatumomab) in adults with acute lymphoblastic leukemia (ALL).

FDA allows marketing of cooling cap to reduce hair loss during chemotherapy
12/09/2015

The U.S. Food and Drug Administration cleared for marketing in the United States the first cooling cap to reduce hair loss (alopecia) in female breast cancer patients undergoing chemotherapy.

FDA approves first recombinant von Willebrand factor to treat bleeding episodes
12/09/2015

The U.S. Food and Drug Administration has approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD).

Skin cells flip between maintenance and healing states, study shows
12/09/2015

From watching high-definition movies, researchers find that human skin cells can flip between two modes of division; one is more suited to wound healing, the other to maintenance.

Mindfulness-based stress reduction reduces chemo brain, Regenstrief and IU study reports
12/09/2015

Participation in a mindfulness-based stress reduction program yields robust and sustained improvement in cancer-related cognitive impairment, a prevalent and potentially debilitating condition that...

Data confirms safety and efficacy profile of XARELTO, with shorter hospital stays, for the treatment of deep vein thrombosis
12/09/2015

Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the results from their real-world study XALIA showing that, in people with deep vein thrombosis (DVT)...

Building the foundations for cancer genomic analysis for research and clinical diagnostics
12/09/2015

An eye-opening article from the International Cancer Genome Consortium (ICGC) was published today in the prestigious journal Nature Communicationsxc.

Study links body fat, weight loss, and chromosome length in breast cancer patients
12/09/2015

It is well documented that a healthy diet and exercise are key in cancer prevention and management, but the exact mechanism hasn't been clear.